Spero Therapeutics, Inc. (SPRO)

2.19 -0.05 (-2.23%) USD  |  NASDAQ  |  Feb 24, 14:05
More

Spero Therapeutics Cash (Quarterly)

Cash (Quarterly) Chart

View Cash (Quarterly) for SPRO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash (Quarterly) Range, Past 5 Years

View Cash (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash (Quarterly) Benchmarks

View Cash (Quarterly) Benchmarks
Start Trial
BioMarin Pharmaceutical, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Cassava Sciences, Inc. Upgrade
Alpha Teknova, Inc. Upgrade
Pyxis Oncology, Inc. Upgrade